Preferred Label : Autologous Colon Cancer Cell Vaccine;
NCIt definition : A personalized, proprietary cancer vaccine composed of sterile, irradiated, non-dividing,
live colon cancer cells obtained from an individual after tumor resection, with potential
immunoactivating and antineoplastic activities. Upon intradermal administration, the
autologous colon cancer cell vaccine activates the immune system and elicits a cytotoxic
T-lymphocytic (CTL) response against the residual colon cancer cells, which results
in tumor cell death. This may prevent cancer recurrence. According to the vaccination
schedule, the first two out of the four doses are co-administered with the immunoadjuvant
bacillus Calmette-Guerin (BCG), which is an attenuated strain of Mycobacterium bovis
that non-specifically enhances the immune response.;
Drug name : OncoVAX;
Origin ID : C1984;
UMLS CUI : C4055425;
Semantic type(s)
- concept_is_in_subset
